A summary of the results of a review of 405 patients with non-Hodgkin's lymphoma at Stanford University.

A résumé of the major advantages of using the Rappaport classification of the non-Hodgkin's lymphomata is presented. The data are taken from a series of 6 papers resulting from a retrospective review of 405 cases at Stanford University. The frequency of nodular lymphomata (44%) is emphasized. The clinical features, response to therapy and natural history of these patients are quite different among the various subgroups. Use of this classification instead of former pathological classifications is urged.